IL310210A - Methods for inhibiting the progression of oxidative retinal diseases - Google Patents
Methods for inhibiting the progression of oxidative retinal diseasesInfo
- Publication number
- IL310210A IL310210A IL310210A IL31021024A IL310210A IL 310210 A IL310210 A IL 310210A IL 310210 A IL310210 A IL 310210A IL 31021024 A IL31021024 A IL 31021024A IL 310210 A IL310210 A IL 310210A
- Authority
- IL
- Israel
- Prior art keywords
- progression
- delay
- methods
- retinal diseases
- oxidative retinal
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
- A61K31/202—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids having three or more double bonds, e.g. linolenic
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
- A61K31/23—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin of acids having a carboxyl group bound to a chain of seven or more carbon atoms
- A61K31/232—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin of acids having a carboxyl group bound to a chain of seven or more carbon atoms having three or more double bonds, e.g. etretinate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
Landscapes
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Chemistry (AREA)
- Ophthalmology & Optometry (AREA)
- Emergency Medicine (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163224690P | 2021-07-22 | 2021-07-22 | |
| US202163224679P | 2021-07-22 | 2021-07-22 | |
| US202163224674P | 2021-07-22 | 2021-07-22 | |
| PCT/US2022/038072 WO2023004151A1 (en) | 2021-07-22 | 2022-07-22 | Methods for inhibiting the progression of oxidative retinal diseases |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IL310210A true IL310210A (en) | 2024-03-01 |
Family
ID=84979648
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL310210A IL310210A (en) | 2021-07-22 | 2022-07-22 | Methods for inhibiting the progression of oxidative retinal diseases |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US20250099415A1 (https=) |
| EP (1) | EP4373479A4 (https=) |
| JP (1) | JP2024526939A (https=) |
| KR (1) | KR20240036651A (https=) |
| AU (1) | AU2022313207A1 (https=) |
| CA (1) | CA3227139A1 (https=) |
| IL (1) | IL310210A (https=) |
| WO (1) | WO2023004151A1 (https=) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2024049497A1 (en) * | 2022-09-02 | 2024-03-07 | Biojiva Llc | Pharmaceutical compositions of d10-docosahexaenoic acid or esters thereof |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20060270739A1 (en) * | 2005-04-28 | 2006-11-30 | Trustees Of Tufts College | Synergistic effects of docosahexaenoic acid (DHA) and carotenoid absorption on macular pigmentation |
| CA2723139A1 (en) * | 2007-07-30 | 2009-02-05 | Board Of Supervisors Of Louisiana State University And Agricultural And Mechanical College | Dha and pedf, a therapeutic composition for nerve and retinal pigment epithelial cells |
| WO2009058815A2 (en) * | 2007-10-29 | 2009-05-07 | Board Of Supervisors Of Louisiana State University And Agricultural And Mechanical College | Lipoxin a4 protection for retinal cells |
| EP3689342A1 (en) * | 2011-04-26 | 2020-08-05 | Retrotope, Inc. | Oxidative retinal diseases |
| CA3005983A1 (en) * | 2015-11-23 | 2017-06-01 | Retrotope, Inc. | Site-specific isotopic labeling of 1,4-diene systems |
| CA3117216A1 (en) * | 2018-11-15 | 2020-05-22 | Retrotope, Inc. | Deuterated compounds, compositions, and uses |
-
2022
- 2022-07-22 JP JP2024503840A patent/JP2024526939A/ja active Pending
- 2022-07-22 IL IL310210A patent/IL310210A/en unknown
- 2022-07-22 CA CA3227139A patent/CA3227139A1/en active Pending
- 2022-07-22 US US18/291,016 patent/US20250099415A1/en active Pending
- 2022-07-22 EP EP22846695.9A patent/EP4373479A4/en active Pending
- 2022-07-22 KR KR1020247005941A patent/KR20240036651A/ko active Pending
- 2022-07-22 AU AU2022313207A patent/AU2022313207A1/en active Pending
- 2022-07-22 WO PCT/US2022/038072 patent/WO2023004151A1/en not_active Ceased
Also Published As
| Publication number | Publication date |
|---|---|
| EP4373479A4 (en) | 2025-11-05 |
| EP4373479A1 (en) | 2024-05-29 |
| KR20240036651A (ko) | 2024-03-20 |
| US20250099415A1 (en) | 2025-03-27 |
| AU2022313207A1 (en) | 2024-02-29 |
| CA3227139A1 (en) | 2023-01-26 |
| WO2023004151A1 (en) | 2023-01-26 |
| JP2024526939A (ja) | 2024-07-19 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL280710A (en) | Methods and compositions for treating mitochondrial disease or disorders and heteroplasmy | |
| IL283372A (en) | Use of cannabinoids in the treatment of epilepsy | |
| IL262608A (en) | Combination treatment of ocular inflammatory disorders and diseases | |
| IL276383B1 (en) | Treatment of ophthalmological diseases | |
| EP3419633A4 (en) | TREATMENT OF ALLERGIC EYE DISEASES WITH CYCLODEXTRINS | |
| HUE059638T2 (hu) | Ízületi gyulladásos betegségek kombinált kezelése | |
| DK3411400T3 (da) | Behandling af inflammatoriske sygdomme med hæmmere af c5a-aktivitet | |
| LT4331584T (lt) | Lanifibranoro deuterintų darinių terapietiniai naudojimai | |
| PL3405215T3 (pl) | Sposoby leczenia choroby danona i innych zaburzeń autofagii | |
| IL283069A (en) | Methods for administering corticosteroids | |
| EP3823646A4 (en) | Mitochondrial augmentation therapy of brain diseases | |
| EP3606535A4 (en) | TREATMENT OF INFLAMMATORY INTESTINAL DISEASES WITH 2'-FUCOSYLLACTOSE COMPOUNDS | |
| IL268720A (en) | Formulations of cannabinoids for the treatment of dermatitis and inflammatory skin diseases | |
| EP3737363A4 (en) | METHODS FOR TREATMENT OF CHRONIC INFLAMMATORY DISEASES | |
| EP4003299A4 (en) | Treatment of skin disorders with topical tapinarof-egfr inhibitor compositions | |
| EP4100002A4 (en) | TREATMENT OF NEUROLOGICAL DISORDERS WITH AVERMECTINS | |
| IL270900A (en) | Treatment of cutaneous disorders | |
| GB201805100D0 (en) | Treatment of sarcopenic diseases | |
| EA201992389A1 (ru) | Замещенные n-арилэтил-2-аминохинолин-4-карбоксамиды и их применение | |
| EP3866795A4 (en) | TREATMENT OF NEUROLOGICAL DISEASES | |
| SI3458067T1 (sl) | Zdravljenje nevroloških obolenj | |
| EP3761982A4 (en) | TREATMENT OF DEMYELINIZATION DISEASES | |
| IL310210A (en) | Methods for inhibiting the progression of oxidative retinal diseases | |
| EP4313024A4 (en) | Treatment of inflammatory diseases | |
| IL308669A (en) | Methods of treating mitochondria-related disorders |